Pharmacotherapy of bone metastases in breast cancer patients – an update

Author： Jacobs Carmel   Simos Demetrios   Addison Christina   Ibrahim Mohammed   Clemons Mark  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.8, 2014-06, pp. : 1109-1118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clodronate: A Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer

By Toni M. Dando   Lynda R. Wiseman  

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 949-962

Adis International

Access to resources Recommend Favorite

Progress in the treatment of bone metastases in cancer patients

By Mackiewicz-Wysocka Malgorzata   Pankowska Magdalena   Wysocki Piotr J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 785-795

Informa Healthcare

Access to resources Recommend Favorite

An update on the pharmacotherapy for endometrial cancer

By Amadio Giulia   Masciullo Valeria   Stefano Letizia   Scambia Giovanni  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. : 2501-2509

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for male breast cancer

By Hayes Teresa  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 6, 2002-06 ,pp. : 701-708

Informa Healthcare

Access to resources Recommend Favorite

Ibandronic Acid: A Review of its Use in the Treatment of Bone Metastases of Breast Cancer

By McCormack Paul L.   Plosker Greg L.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 711-728

Adis International

Access to resources Recommend Favorite